Cancer Research 09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 3352-3354, December 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drysdale, J. W.
Right arrow Articles by Singer, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drysdale, J. W.
Right arrow Articles by Singer, R. M.

Carcinofetal Human Isoferritins in Placenta and HeLa Cells1

James W. Drysdale2 and Robert M. Singer

Department of Biochemistry and Pharmacology and Cancer Research Center, Tufts University School of Medicine, Boston, Massachusetts 02111

Ferritins from normal liver, placenta, and HeLa cells were resolved into their constituent isoferritins by gel electrofocusing. HeLa cells gave only two isoferritins. These isoferritins were not detected in liver. Placenta and liver each contained about six isoferritins with several in common. In addition, placenta contained two isoferritins that appeared to correspond to the HeLa isoferritins. Both of the carcinofetal forms in placenta and HeLa cells were recognized by antibodies prepared against normal adult liver ferritin.

1 This work was supported by Grants AM 16781 and CA 14406 and 12924.

2 To whom reprint requests may be addressed.

Received 3/11/74. Accepted 8/28/74.




This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
R. Maymon, E. Jauniaux, and C. Moroz
Enhanced expression of the immunoregulator, p43-placental isoferritin, in Down's syndrome placentae and fetal kidneys
Mol. Hum. Reprod., December 1, 2002; 8(12): 1125 - 1128.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.